Navigation Links
$100 million supercomputing program boosts Australian medical research capacity

Under a new Victorian Life Sciences Computation Initiative, The University of Melbourne in Melbourne Australia will host a $100 million supercomputing program and facility dedicated to life sciences.

The initiative will develop the most powerful supercomputer and leading computational biology facility dedicated to life sciences research in the world.

Funding of $50 million has been provided by the Victorian State Government, as announced by the Victorian Premier John Brumby at Bio2008 in San Diego, USA overnight.

The Hon. Theo Theophanous, Victorian Minister for Industry and Trade, Information and Communication Technology, and Major Projects detailed the State Government's vision for the project at a special media announcement at the University of Melbourne today.

Vice Chancellor Professor Glyn Davis explained how Australia's first life sciences dedicated supercomputer will impact Victorian researchers and where the program will be located at the University of Melbourne.

"As part of the initiative, the University of Melbourne will develop a Life Sciences Computation Centre to undertake the peak computing operations and provide computational biology expertise to the institutions throughout the Melbourne Parkville Precinct," said Professor Glyn Davis, Vice-Chancellor of the University of Melbourne.

Professor Davis says researchers from the Parkville Precinct, Monash University and other leading Victorian research institutions will have access to the peak computing facility, encouraging a collaborative approach to medical research.

"We are tremendously excited about the potential for this initiative to expand dramatically the State's and the University's capacity in bioinformatics, computational biology and advanced biomedical image analysis."

"The far reaching vision and scale of this initiative will combine Victoria's already globally competitive biomedical research capability with computational infrastructure specially designed for the life sciences, equal to the best in the world" said Professor Davis.

"Life sciences research is being transformed by the application of rapid advances in computational biology, powered by innovations in very high performance computers and data management, "said Professor James Angus, Dean of the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne.

"This will lead to major improvements in public health outcomes - particularly in the areas of cancer, cardiovascular and neurological disease, chronic inflammatory diseases, bone diseases and diabetes."

The University of Melbourne intends to call for expressions of interest for the Life Sciences Computation Centre and peak computing facility (PCF) in 2008, with the major PCF installations planned for 2009 and 2011.


Contact: Rebecca Scott
University of Melbourne

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm of ... obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer ... 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified that on ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood Treatment Center ... with eating disorders as a result of the $20,000 raised at the center’s ... Fox Run Golf Club in Eureka, will help individuals who otherwise might not ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Italian therapeutic drug monitoring ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: